WILLIAM J. FEBBO - 16 Jun 2023 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role
Director
Signature
/s/ Paul Ginocchio, Attorney-in-Fact
Issuer symbol
AUGX
Transactions as of
16 Jun 2023
Net transactions value
$0
Form type
4
Filing time
16 Jun 2023, 17:50:31 UTC
Previous filing
20 Apr 2023
Next filing
22 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Options Exercise +52,632 +60% 140,985 16 Jun 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Restricted Stock Units Options Exercise $0 -52,632 -100% $0.000000* 0 16 Jun 2023 Common Stock 52,632 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
F2 On June 16, 2022 (the "Grant Date"), the reporting person was granted 52,632 RSUs which vested in full on the one-year anniversary of the Grant Date.